Surprisingly, however, the supplements were counterproductive for those with early AMD, negating the benefits of omega-3 fats, and even appeared to increase the risk of disease progression.
Many patients are being diagnosed at a late stage of disease progression resulting in delayed initiation of ART and high rates of mortality in the first year of treatment.
Biomarkers can also reveal changes in a biological pathway that correlate with disease progression, or even the risk of disease progression.
Staging to determine the state of disease progression.